These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
128 related articles for article (PubMed ID: 6129877)
1. [Behavior of arterial pressure, hemodynamic parameters, sympathetic nervous system activity and plasma volume during treatment with a vasodilating and beta-blocking drug in essential hypertension patients]. Fariello R; Alicandri C; Agabiti-Rosei E; Romanelli G; Montini E; Muiesan ML; Minniti P; Castellano M; Beschi M; Boni E; Zaninelli A; Micheli P; Platto L; Leto Di Priolo S; Muiesan G Boll Soc Ital Cardiol; 1981; 26(11):1871-4. PubMed ID: 6129877 [No Abstract] [Full Text] [Related]
2. Changes in blood pressure, fluid volumes and glomerular filtration rate during long-term treatment with prizidilol, an antihypertensive drug with combined vasodilatator and beta-adrenoceptor blocking actions. Andersen GS; Hartling OJ; Hein HO; Leth A Dan Med Bull; 1985 Oct; 32(5):280-3. PubMed ID: 2865088 [TBL] [Abstract][Full Text] [Related]
3. [Continuous intra-arterial pressure recording for 24 hours under basal conditions and during therapy with prizidilol, a vasodilating and beta-blocking drug]. Fariello R; Alicandri C; Boni E; Montini E; Minniti P; Cinquegrana A; Guarienti P; Zaninelli A; Agabiti-Rosei E; Muiesan G Cardiologia; 1983 Feb; 28(2):127-31. PubMed ID: 6142722 [No Abstract] [Full Text] [Related]
4. Dose-response relationship of prizidilol hydrochloride (SK&F 92657): a comparison between acute and chronic effects in patients with essential hypertension. Pedrinelli R; Abdel-Haq B; Magagna A; Leto di Priolo S; Simonini N; Salvetti A Int J Clin Pharmacol Res; 1984; 4(2):155-63. PubMed ID: 6147320 [TBL] [Abstract][Full Text] [Related]
5. [Combination of betablocking-vasodilator and diuretic agents in the treatment of arterial hypertension. Changes in Hemodynamics and plasma-renin levels]. Fernández-Andrade C; Herrera Carranza M; Villalobos Galán E; Mateos Aguilar J; Quereda C; Navarro R; Martinez Martin A; Mendoza Llera M Rev Clin Esp; 1978 Mar; 148(5):491-6. PubMed ID: 27844 [No Abstract] [Full Text] [Related]
6. Management of hypertension. Clinical and hemodynamic studies with special reference to patients refractory to treatment. Andersson O Acta Med Scand Suppl; 1977; 617():1-62. PubMed ID: 28637 [No Abstract] [Full Text] [Related]
7. [Effects of cadralazine (ISF 2469) on water-sodium balance and on essential arterial hypertension]. Lavezzaro GC; Gastaldo D; Noussan P; Bensoni M; Parini J; Angelino PF Minerva Cardioangiol; 1981 Oct; 29(10):527-34. PubMed ID: 7322375 [No Abstract] [Full Text] [Related]
8. [Treatment of hypertension with a combination of pyridopyridazine derivative with a beta-receptor blocker. Studies on the hemodynamic course (author's transl)]. Lehmann HU; Witt E; Hochrein H MMW Munch Med Wochenschr; 1978 Jun; 120(23):803-6. PubMed ID: 26870 [TBL] [Abstract][Full Text] [Related]
9. Dose-response curve and time course of the antihypertensive effect of SKF 92 657, a beta-receptor-blocking and vasodilating compound. Leonetti G; Terzoli L; Sala C; Bianchini C; Zanchetti A Clin Sci (Lond); 1980 Dec; 59 Suppl 6():461s-463s. PubMed ID: 6108817 [TBL] [Abstract][Full Text] [Related]
10. Prizidilol in essential hypertension: long-term effects on plasma volume, extracellular fluid volume, and central hemodynamics at rest and during exercise. Lund-Johansen P; Omvik P J Cardiovasc Pharmacol; 1982; 4(6):1012-7. PubMed ID: 6185765 [TBL] [Abstract][Full Text] [Related]
11. [Beta blocking agents and arterial hypertension]. Squadrito G G Clin Med; 1979 May; 60(5):347-65. PubMed ID: 39861 [No Abstract] [Full Text] [Related]
12. [Vasodilating beta blockers as effective antihypertensive agents. Results of a multicenter observational study]. von Fallois J; Faulhaber HD MMW Fortschr Med; 2000 Jun; 142(24):45. PubMed ID: 10895582 [No Abstract] [Full Text] [Related]
13. [Prospects of beta-blocking treatment in arterial hypertension]. Cosma M Rev Med Chir Soc Med Nat Iasi; 1979; 83(4):573-8. PubMed ID: 45049 [No Abstract] [Full Text] [Related]
14. [Essential hypertension: Renin and aldosterone, key to pathogeny and therapy?]. Bühler FR Schweiz Med Wochenschr; 1974 Jul; 104(29):1013-22. PubMed ID: 4153738 [No Abstract] [Full Text] [Related]
15. [Modern treatment of hypertension in older patients (author's transl)]. Klein W Aktuelle Gerontol; 1980 Jan; 10(1):21-5. PubMed ID: 6106402 [TBL] [Abstract][Full Text] [Related]
16. Randomized controlled trial of ACE-inhibitors and beta-blockers with and without vasodilating activity in chronic glomerulonephritis. Erley CM; Klass M; Krämer D; Berger E; Heyne N; Braun N; Wolf S; Risler T Int J Clin Pharmacol Ther; 1996 Nov; 34(11):504-9. PubMed ID: 8937934 [TBL] [Abstract][Full Text] [Related]
17. Drug treatment of high blood pressure. Hutchins LN Nurs Clin North Am; 1981; 16(2):365-76. PubMed ID: 6167937 [TBL] [Abstract][Full Text] [Related]
18. Levosimendan is not effective in reducing pulmonary pressures in patients with idiopathic pulmonary arterial hypertension: report of two cases. Cavusoglu Y; Beyaztas A; Birdane A; Ata N J Cardiovasc Med (Hagerstown); 2009 Jun; 10(6):503-7. PubMed ID: 19346968 [TBL] [Abstract][Full Text] [Related]
19. [Evaluation of the effectiveness of the long-term treatment of hypertension patients. I. Changes in hemodynamics and myocardial function]. Erina EV; Charyev KhE Ter Arkh; 1984; 56(9):24-30. PubMed ID: 6151257 [TBL] [Abstract][Full Text] [Related]
20. [Essential arterial hypertension: initial therapeutic strategy or how to normalize arterial pressure]. Gassia JP; Durand D; Suc JM Rev Prat; 1979 Dec; 29(57):4395-407. PubMed ID: 44764 [No Abstract] [Full Text] [Related] [Next] [New Search]